Fig. 2From: Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell deathRepresentative photographs showing morphological changes in HepG2 and WI-38 cells exposed to IC50/2 concentration of Amygdalin or Sorafenib and combination treatment for 24 and 48 h. Images were taken using an inverted phase contrast microscope at ×100. Scale bar 50 μmBack to article page